FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Sodium polystyrene sulfonate by Chartwell RX, LLC under the referenced ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)